References
- KandulskiA, MalfertheinerP. Gastroesophageal reflux disease—from reflux episodes to mucosal inflammation. Nat Rev Gastroenterol Hepatol. 2012;9(1):15. doi:10.1038/nrgastro.2011.210
- YamasakiT, HemondC, EisaM, GanocyS, FassR. The changing epidemiology of gastroesophageal reflux disease: are patients getting younger? J Neurogastroenterol Motil. 2018;24(4):559. doi:10.5056/jnm1814030347935
- Koda-KimbleMA. Koda-Kimble and Young’s Applied Therapeutics: The Clinical Use of Drugs. Lippincott Williams & Wilkins; 2012.
- KahrilasPJ, McCollK, FoxM, et al. The acid pocket: a target for treatment in reflux disease? Am J Gastroenterol. 2013;108(7):1058. doi:10.1038/ajg.2013.13223629599
- De RuighA, RomanS, ChenJ, PandolfinoJE, KahrilasPJ. Gaviscon double action liquid (antacid & alginate) is more effective than antacid in controlling post‐prandial oesophageal acid exposure in GERD patients: a double‐blind crossover study. Aliment Pharmacol Ther. 2014;40(5):531–537.25041141
- ThomasE, WadeA, CrawfordG, JennerB, LevinsonN, WilkinsonJ. Randomised clinical trial: relief of upper gastrointestinal symptoms by an acid pocket‐targeting alginate–antacid (gaviscon double action)–a double‐blind, placebo‐controlled, pilot study in gastro‐oesophageal reflux disease. Aliment Pharmacol Ther. 2014;39(6):595–602. doi:10.1111/apt.1264024471505
- YamaokaY. Mechanisms of disease: Helicobacter pylori virulence factors. Nat Rev Gastroenterol Hepatol. 2010;7(11):629. doi:10.1038/nrgastro.2010.15420938460
- PolkDB, PeekRM Jr. Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer. 2010;10(6):403. doi:10.1038/nrc285720495574
- HageN, HowardT, PhillipsC, et al. Structural basis of Lewisb antigen binding by the Helicobacter pylori adhesin BabA. Sci Adv. 2015;1(7):e1500315. doi:10.1126/sciadv.150031526601230
- PangSS, NguyenSTS, PerryAJ, et al. The three-dimensional structure of the extracellular adhesion domain of the sialic acid-binding adhesin SabA from Helicobacter pylori. J Biol Chem. 2014;289(10):6332–6340.24375407
- MégraudF. The challenge of Helicobacter pylori resistance to antibiotics: the comeback of bismuth-based quadruple therapy. Therap Adv Gastroenterol. 2012;5(2):103–109. doi:10.1177/1756283X11432492
- MegraudF, CoenenS, VersportenA, et al. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut. 2013;62(1):34–42. doi:10.1136/gutjnl-2012-30225422580412
- ThungI, AraminH, VavinskayaV, et al. The global emergence of Helicobacter pylori antibiotic resistance. Aliment Pharmacol Ther. 2016;43(4):514–533. doi:10.1111/apt.1349726694080
- St-PierreC, OuelletM, TremblayMJ, SatoS. Galectin-1 and HIV-1 infection In: Fukuda M, editor. Methods in Enzymology. Vol. 480 Elsevier; 2010:267–294.20816214
- VastaGR. Roles of galectins in infection. Nat Rev Microbiol. 2009;7(6):424. doi:10.1038/nrmicro214619444247
- TrincheraM, AronicaA, Dall’OlioF. Selectin ligands sialyl-Lewis a and sialyl-Lewis x in gastrointestinal cancers. Biology. 2017;6(1):16. doi:10.3390/biology6010016
- GonçalvesIC, MagalhãesA, CostaAM, et al. Bacteria-targeted biomaterials: glycan-coated microspheres to bind Helicobacter pylori. Acta Biomater. 2016;33:40–50. doi:10.1016/j.actbio.2016.01.02926805428
- ParreiraP, MagalhãesA, ReisC, BorénT, LeckbandD, MartinsM. Bioengineered surfaces promote specific protein–glycan mediated binding of the gastric pathogen Helicobacter pylori. Acta Biomater. 2013;9(11):8885–8893. doi:10.1016/j.actbio.2013.06.04223831721
- NamSY, ChoiIJ, RyuKH, KimBC, KimCG, NamB-H. Effect of Helicobacter pylori infection and its eradication on reflux esophagitis and reflux symptoms. Am J Gastroenterol. 2010;105(10):2153. doi:10.1038/ajg.2010.25120571493
- YaghoobiM, FarrokhyarF, YuanY, HuntRH. Is there an increased risk of GERD after Helicobacter pylori eradication?: a meta-analysis. Am J Gastroenterol. 2010;105(5):1007. doi:10.1038/ajg.2009.73420087334
- BugaytsovaJA, BjörnhamO, ChernovYA, et al. Helicobacter pylori adapts to chronic infection and gastric disease via pH-responsive BabA-mediated adherence. Cell Host Microbe. 2017;21(3):376–389. doi:10.1016/j.chom.2017.02.01328279347
- LaiS-W, LaiH-C, LinC-L, LiaoK-F. Proton pump inhibitors and risk of gastric cancer in a case–control study. Gut. 2019;68(4):765–767. doi:10.1136/gutjnl-2018-31637129661803
- PoulsenA, ChristensenS, McLaughlinJ, et al. Proton pump inhibitors and risk of gastric cancer: a population-based cohort study. Br J Cancer. 2009;100(9):1503–1507. doi:10.1038/sj.bjc.660502419352380
- YadegarA, Mohabati MobarezA, ZaliMR. Genetic diversity and amino acid sequence polymorphism in Helicobacter pylori CagL hypervariable motif and its association with virulence markers and gastroduodenal diseases. Cancer Med. 2019;8(4):1619–1632. doi:10.1002/cam4.194130873747
- FarziN, YadegarA, AghdaeiHA, YamaokaY, ZaliMR. Genetic diversity and functional analysis of oipA gene in association with other virulence factors among Helicobacter pylori isolates from Iranian patients with different gastric diseases. Infect Genet Evol. 2018;60:26–34. doi:10.1016/j.meegid.2018.02.01729452293
- BöttgerS, MelzigMF. The influence of saponins on cell membrane cholesterol. Bioorg Med Chem. 2013;21(22):7118–7124. doi:10.1016/j.bmc.2013.09.00824084294
- McMahonRJ. Avidin-Biotin Interactions: Methods and Applications. Springer Science & Business Media; 2008.
- ChiversCE, CrozatE, ChuC, MoyVT, SherrattDJ, HowarthM. A streptavidin variant with slower biotin dissociation and increased mechanostability. Nat Methods. 2010;7(5):391. doi:10.1038/nmeth.145020383133
- MittalR, BruchezMP. Biotin-4-fluorescein based fluorescence quenching assay for determination of biotin binding capacity of streptavidin conjugated quantum dots. Bioconjug Chem. 2011;22(3):362–368. doi:10.1021/bc100321c21314110
- SunS, HuangX, MaM, et al. Systematic evaluation of avidin–biotin interaction by fluorescence spectrophotometry. Spectrochim Acta A Mol Biomol Spectrosc. 2012;89:99–104. doi:10.1016/j.saa.2011.12.00322261100
- WanerMJ, MascottiDP. A simple spectrophotometric streptavidin–biotin binding assay utilizing biotin-4-fluorescein. J Biochem Biophys Methods. 2008;70(6):873–877. doi:10.1016/j.jbbm.2007.06.00117669504
- BenderDA. Nutritional Biochemistry of the Vitamins. Cambridge university press; 2003.
- LiebesaY, MarksaRS. Optical fiber immunosensors and genosensors for the detection of viruses. Viral Diagn. 2014;2:343.
- ZhaoY, LiY, HuJ, et al. The effect of Helicobacter pylori eradication in patients with gastroesophageal reflux disease: a meta-analysis of randomized controlled studies. Dig Dis. 2020;1–8. doi:10.1159/000504086
- NaHK, LeeJH, ParkSJ, et al. Effect of Helicobacter pylori eradication on reflux esophagitis and GERD symptoms after endoscopic resection of gastric neoplasm: a single-center prospective study. BMC Gastroenterol. 2020;20(1):1–7. doi:10.1186/s12876-020-01276-1
- International Standards Organization. ISO 10993-5. Biological Evaluation of Medical Devices. Tests for in vitro Cytotoxicity. Geneva: International Standards Organization; 2009.